Medtech & Pharma Platform Association’s Post

📣 Why should the pharmaceutical industry care about pathway innovation? Welcome to the fourth instalment in TCC Health's Spotlight Series. Introducing our Chief Executive Officer, Sangeeta Patil. Sangeeta has experience from both in-house and consultancy, so she knows first hand how tough it can be to bring innovative solutions to the healthcare system. Sangeeta has worked extensively with global pharma to solve pathway challenges which improve access to treatment and optimise care across therapy areas. With that in mind, we asked her: Why should pharma care about pathway innovation? See what she answered below 👇 #pharmainnovation #innovationconsultancy #pathwayinnovation #healthcareinnovation #pharmastrategy

When selecting our investments, we prioritise the themes outlined in our strategy. Health & life sciences is one of these themes and encompasses companies that innovate and develop solutions for health problems and improve quality of lives. 🧬🔬 Operating in the intersection of global pharmaceutical industry and healthcare, BC Platforms is a great example of such a company from our portfolio! Watch the short video below and see what BC Platforms does, exactly. 👇 You can also read more in a case article: https://lnkd.in/dv6YagJm #HealthandLifeSciences #HealthTech #VentureCapital #GrowthEquity

Looking to break into the pharmaceutical industry in 2025? Understanding what pharma companies want—like compliance, scalability, and innovative solutions—can make all the difference. 👉 Join us on Zoom: https://okt.to/B59ZtP Join us tomorrow, Tuesday, December 17th, for a hands-on session with healthcare innovation expert Marco De Polo to explore the challenges and opportunities of selling into pharma in 2025. Marco will share insights from his 20+ years of experience, including: 🔹 Aligning your solution with pharma needs and expectations. 🔹Overcoming challenges like compliance and scalability. 🔹Positioning your product and build impactful partnerships. This session is a great opportunity for anyone looking to deepen their understanding of the pharma landscape and elevate their approach in 2025 and beyond. Eden Eini Yael Pomerantz Yariv Becher Chanel Itzhaki Ganor #PharmaInnovation #HealthcareTech

Let's get real. Medical sales in the UK isn't easy. With evolving PCNs and ICBs, pharma companies face increasing complexity in engagement and access. These structures aim to streamline healthcare—but in reality, they add new barriers. At Nzyme, our Teams Flexed approach helps pharma cut through the noise with tailored strategies that drive smoother engagement, ensure compliance, and unlock market access success. ✅ Let’s turn challenges into opportunities. 💡 #MarketAccess #Pharma #HealthcareInnovation

Read our most recent article on the recent Court decisions of making net prices visible in Spain, and the important impact for pharmaceutical manufacturers and the Spanish Healthcare System. 

Explore the Latest Developments in Healthcare! 🔍 In this week's FMI Weekly Market Digest, we highlight pivotal moments in the healthcare sector that are driving innovation and collaboration. Join us as we explore innovative solutions and strategic partnerships that promise to enhance patient care and drive industry growth. Catalent Pharma Solutions FDA Pfizer Abbott News Credit: Contract Pharma ASH Clinical News Reuters #Abbott 👉 Watch the video for insights that matter! #Healthcare #MarketDigest #Innovation #PatientCare #HealthcareTrends

💡 The role of senior digital leaders in market access strategy 💡 Incorporating advice from senior digital leaders is vital when crafting effective market access strategies for pharmaceutical and medtech products. These experts bring unique insights into: ✅ The role of data in clinical decision-making ✅ The importance of understanding full clinical pathways in a patient’s journey ✅ Aligning strategies with the latest digital innovations At Mtech Access, our NHS Associates include senior digital leaders who offer invaluable guidance to ensure strategies are grounded in real-world insights and responsive to the evolving healthcare landscape. This comprehensive approach helps drive better patient outcomes and supports more efficient healthcare delivery. Email info@mtechaccess.co.uk to learn how our network of NHS Associates can help shape your market access strategy. #marketaccess #healthcareinnovation #digitalhealth #medtech #pharma #patientoutcomes #NHS #NHSWhispers

How will Spain’s push for drug price transparency affect the pharma industry and the Spanish National Health System? In our most recent blog, our experts provide insights on the potential impacts, challenges, and what it means for future access to pharma innovations. Read more here: skp.link/mxf #BetterMarketAccess #Pharma #Healthcare #Innovation #SimonKucher

In this article, together with my colleagues Rainer Opgen-Rhein and Alicia Rodríguez Moreno, we assess the potential economic and commercial implications for biopharma companies of increasing drug price transparency in Spain. Get in touch with us to know more! #SimonKucher #pharmainnovation #prices